source
- Boston Scientific stops sales of Imager II catheters after tip defect linked to two injuriesBoston Scientific issued a letter on August 24 advising customers to remove all Imager II angiographic catheters from use or sale after discovering a manufacturing problem. The problem involves re…
- GSK to start Phase 3 trial of mRNA flu vaccine after strong mid-stage resultsGSK announced it will begin a Phase 3 trial of its mRNA-based influenza vaccine, with enrollment slated to start in September. In a Phase 2 study of 971 adults, the investigational vaccine, which…